Diabetic Retinopathy Raises Stroke Risk: Study
PublishedEye damage from retinopathy may also mean that someone has small blood vessel damage in the brain, according to a new study… Read More “Diabetic Retinopathy Raises Stroke Risk: Study”
News and Research
Scientific research is constantly evolving. Stay up to date and learn about new treatments in the pipeline, research trends, technologies to watch and more.
Diabetes Control Is Often Mismatched to Needs: Study
PublishedOlder people with the least to gain from tight blood glucose control are more likely to have it as a treatment goal, new research shows… Read More “Diabetes Control Is Often Mismatched to Needs: Study”
Trijardy XR: New Type 2 Diabetes Medication Approved
PublishedThe U.S. Food and Drug Administration (FDA) has just approved Trijardy XR, a diabetes medication that combines three diabetes drugs in a single tablet… Read More “Trijardy XR: New Type 2 Diabetes Medication Approved”
Medtronic Recalls Some Insulin Pumps; FDA Requests Withdrawal of Weight-Loss Drug
PublishedFind out if you’re affected by safety concerns that emerged last week in the news… Read More “Medtronic Recalls Some Insulin Pumps; FDA Requests Withdrawal of Weight-Loss Drug”
FDA Not Recommending Metformin Recall
PublishedThe drug oversight agency recommended no recalls based on its tests of this popular type 2 diabetes drug… Read More “FDA Not Recommending Metformin Recall”
New Smart Insulin Patch Could Be a Game Changer
PublishedA team of researchers and bioengineers at three schools have reported they have developed a smart insulin patch that could revolutionize diabetes treatment… Read More “New Smart Insulin Patch Could Be a Game Changer”
Very Low Blood Glucose Reduces Cognitive Ability in Older Adults With Type 1: Study
PublishedHypoglycemia affected a range of cognitive abilities, including language and executive function… Read More “Very Low Blood Glucose Reduces Cognitive Ability in Older Adults With Type 1: Study”
CVS Announces Option With No Out-of-Pocket Costs for Diabetes Drugs
PublishedEmployers and health insurers could opt into the program at no extra cost to themselves or members… Read More “CVS Announces Option With No Out-of-Pocket Costs for Diabetes Drugs”
Meijer Ends Free Medication Program
PublishedMeijer has just announced that it will no longer be offering free prescriptions for the diabetes drug metformin and cholesterol medicine atorvastatin… Read More “Meijer Ends Free Medication Program”
Eli Lilly Announces New Lower-Cost Insulin Options
PublishedThe insulin maker is expanding its lineup of “authorized generic” versions of its products… Read More “Eli Lilly Announces New Lower-Cost Insulin Options”
